학술논문
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study
Document Type
Article
Author
Source
In: Clinical Lung Cancer . (Clinical Lung Cancer, May 2024, 25(3):266-273.e5)
Subject
Language
English
ISSN
19380690
15257304
15257304